Starbucks Corp. sell BiotechBee
Start price
22.09.22
/
60%
€86.57
Target price
31.12.24
€75.00
Performance (%)
5.46%
End price
21.12.22
€91.30
Summary
This prediction ended on 21.12.22 with a price of €91.30. The SELL prediction by BiotechBee shows the price for Starbucks Corp. slightly increased by 5.46% during the runtime of the prediction. Dividends of €0.53 are taken into consideration when calculating the performance. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Starbucks Corp. | -1.222% | -1.222% | 12.053% | -1.469% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
According to BiotechBee what are the pros and cons of Starbucks Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Starbucks Corp. diskutieren
Sell mit Kursziel 75,0